BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37074867)

  • 1. Updated Salivary Gland Immunohistochemistry: A Review.
    Swid MA; Li L; Drahnak EM; Idom H; Quinones W
    Arch Pathol Lab Med; 2023 Dec; 147(12):1383-1389. PubMed ID: 37074867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of translocation-associated immunohistochemical stains in the fine-needle aspiration diagnosis of salivary gland neoplasms.
    Foo WC; Jo VY; Krane JF
    Cancer Cytopathol; 2016 Jun; 124(6):397-405. PubMed ID: 26882287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusion oncogenes in salivary gland tumors: molecular and clinical consequences.
    Stenman G
    Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S12-9. PubMed ID: 23821214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Pathology of Salivary Gland Neoplasms: Diagnostic, Prognostic, and Predictive Perspective.
    Toper MH; Sarioglu S
    Adv Anat Pathol; 2021 Mar; 28(2):81-93. PubMed ID: 33405400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLAG1: An Immunohistochemical Marker with Limited Utility in Separating Pleomorphic Adenoma from Other Basaloid Salivary Gland Tumors.
    Avadhani V; Cohen C; Siddiqui MT
    Acta Cytol; 2016; 60(3):240-5. PubMed ID: 27463119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic Salivary Gland Neoplasms: Diagnostic Approach With a Focus on Ancillary Studies.
    Ribeiro EA; Maleki Z
    Adv Anat Pathol; 2022 Nov; 29(6):365-372. PubMed ID: 36044380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted RNA sequencing in the routine clinical detection of fusion genes in salivary gland tumors.
    Bubola J; MacMillan CM; Demicco EG; Chami RA; Chung CT; Leong I; Marrano P; Onkal Z; Swanson D; Veremis BM; Weinreb I; Zhang L; Antonescu CR; Dickson BC
    Genes Chromosomes Cancer; 2021 Oct; 60(10):695-708. PubMed ID: 34176176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMGA2-WIF1 Rearrangements Characterize a Distinctive Subset of Salivary Pleomorphic Adenomas With Prominent Trabecular (Canalicular Adenoma-like) Morphology.
    Agaimy A; Ihrler S; Baněčková M; Costés Martineau V; Mantsopoulos K; Hartmann A; Iro H; Stoehr R; Skálová A
    Am J Surg Pathol; 2022 Feb; 46(2):190-199. PubMed ID: 34324456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenoid cystic carcinoma cytology: Salivary gland and nonsalivary gland.
    Chowsilpa S; An D; Maleki Z
    Diagn Cytopathol; 2020 Dec; 48(12):1282-1289. PubMed ID: 32809258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolving role of molecular pathology in the diagnosis of salivary gland tumours with potential pitfalls.
    Kaur K; Mehta S; Vanik S; Trivedi P; Banerjee N; Dhar H; Datta S; Karanjai S
    Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):3769-3783. PubMed ID: 35267084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular markers in salivary gland tumors: their use in diagnostic and prognostic workup].
    Fehr A; Stenman G; Bullerdiek J; Löning T
    Pathologe; 2009 Nov; 30(6):466-71. PubMed ID: 19784654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant PLAG1 expression in pleomorphic adenomas of the salivary gland: a molecular genetic and immunohistochemical study.
    Matsuyama A; Hisaoka M; Nagao Y; Hashimoto H
    Virchows Arch; 2011 May; 458(5):583-92. PubMed ID: 21394649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt/β-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland.
    Sato M; Yamamoto H; Hatanaka Y; Nishijima T; Jiromaru R; Yasumatsu R; Taguchi K; Masuda M; Nakagawa T; Oda Y
    Pathol Res Pract; 2018 Apr; 214(4):586-592. PubMed ID: 29496310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.
    Chiosea SI; Thompson LD; Weinreb I; Bauman JE; Mahaffey AM; Miller C; Ferris RL; Gooding WE
    Cancer; 2016 Oct; 122(20):3136-3144. PubMed ID: 27379604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands.
    Skálová A; Hyrcza MD; Leivo I
    Head Neck Pathol; 2022 Mar; 16(1):40-53. PubMed ID: 35312980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LEF-1: Diagnostic utility in distinguishing basaloid neoplasms of the salivary gland.
    Schmitt AC; Griffith CC; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2017 Dec; 45(12):1078-1083. PubMed ID: 28972308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility of PLAG1 immunohistochemical determination in salivary gland tumors.
    Rotellini M; Palomba A; Baroni G; Franchi A
    Appl Immunohistochem Mol Morphol; 2014; 22(5):390-4. PubMed ID: 23958548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on molecular diagnostics of squamous and salivary gland tumors of the head and neck.
    Hunt JL
    Arch Pathol Lab Med; 2011 May; 135(5):602-9. PubMed ID: 21526958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic role of fine needle aspiration cytology (FNAC) in the evaluation of salivary gland swelling: an institutional experience.
    Naz S; Hashmi AA; Khurshid A; Faridi N; Edhi MM; Kamal A; Khan M
    BMC Res Notes; 2015 Mar; 8():101. PubMed ID: 25879702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine-Needle Aspiration Cytology of Cellular Basaloid Neoplasms of the Salivary Gland.
    Cantley RL
    Arch Pathol Lab Med; 2019 Nov; 143(11):1338-1345. PubMed ID: 31509452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.